Compound ID | 389
Class: Beta-lactam (penem)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Bacterial DNA-directed RNA polymerase; structurally similar to both tirandamycin and streptolydigin. Potent against a number of anaerobes. |
Institute where first reported: | Abbott Laboratories, USA |
Year first mentioned: | 1987 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Chemical structure(s): | |
Canonical SMILES: | C/C(=C\[C@@H](C)[C@@H]1[C@@H](C)[C@H]2C=CC3(CO3)[C@](C)(O2)O1)/C=C/C(=C/4\C(=O)CNC4=O)/O |
Isomeric SMILES: | C[C@H]1[C@H]2C=CC3(CO3)[C@](O2)(O[C@@H]1[C@H](C)/C=C(\C)/C=C/C(=C/4\C(=O)CNC4=O)/O)C |
InChI: | InChI=1S/C22H27NO6/c1-12(5-6-15(24)18-16(25)10-23-20(18)26)9-13(2)19-14(3)17-7-8-22(11-27-22)21(4,28-17)29-19/h5-9,13-14,17,19,24H,10-11H2,1-4H3,(H,23,26)/b6-5+,12-9+,18-15-/t13-,14+,17-,19-,21-,22?/m1/s1 |
InChI Key: | LTYHWFXVSQHTQH-BWPJEIAHSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/54717174 |
External links: | |
Guide to Pharmacology: | tirandalydigin |
Citation: | http://www.ncbi.nlm.nih.gov/pubmed/1517158 |